Company Name Aminex Therapeutics
Mailing Address 11335 NE 122nd Way Kirkland, WA 98034 USA
Company Description Aminex Therapeutics, Inc., is a drug development company focused on discovery, development, and commercialization of a new subclass of cancer immunotherapies known as suppressor cell modulators (SCMs).
Proceeds Purposes The proceeds will be used to finalize Aminex’s preclinical testing and prepare for Phase 1/2A human clinical trials to start midyear 2016. Our patented AMX-513 combination therapy enables the immune system to attack cancer by regulating myeloid-derived suppressor cells.